CRSP
CRISPR Therapeutics AG
Stock
$55.43−0.01 (−0.02%)Close Oct 2, 2026
Adjusted price
−23.88% total return, past year
Key statistics
- Market cap
- $5.4B
- P/E (TTM)
- —
- 52-week range
- $44.34$76.78
- Beta (5Y monthly)
- 1.75
- Median dollar volume
- $79.9M
- Shares outstanding
- 96.7M
- Revenue, last 12 months
- $13M
- Sector
- Health Care
- First close
- Oct 19, 2016
Returns
Total
- 1M
- −2.6%
- YTD
- +5.7%
- 1Y
- −23.9%
Per year
- 3Y
- +9.3%
- 5Y
- −13.0%
- Since 2016
- +14.8%
Financials
Annual returns
2016 from Oct 19 · 2026 through Oct 2